4//SEC Filing
Gillies Hunter 4
Accession 0001415889-24-009596
CIK 0001798749other
Filed
Mar 31, 8:00 PM ET
Accepted
Apr 1, 6:00 PM ET
Size
8.8 KB
Accession
0001415889-24-009596
Insider Transaction Report
Form 4
Gillies Hunter
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2024-03-28$2.14/sh+9,000$19,260→ 12,251 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-03-28−9,000→ 89,510 totalExercise: $2.14Exp: 2031-04-01→ Common Stock (9,000 underlying) - Sale
Common Stock
2024-03-28$29.50/sh−9,000$265,500→ 3,251 total
Footnotes (2)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 19, 2023.
- [F2]A total of 109,640 shares subject to an employee stock option were granted on April 2, 2021, with the first installment vested on July 4, 2021, with shares vesting in 48 substantially equal monthly installments.
Documents
Issuer
Aerovate Therapeutics, Inc.
CIK 0001798749
Entity typeother
Related Parties
1- filerCIK 0001868997
Filing Metadata
- Form type
- 4
- Filed
- Mar 31, 8:00 PM ET
- Accepted
- Apr 1, 6:00 PM ET
- Size
- 8.8 KB